Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
CaPre
Grace Therapeutics
Hypertriglyceridemia
2 trials -
FF/UMEC/VI
Grace Therapeutics
Asthma
1 trial -
GS-100
Grace Therapeutics
NGLY1 Deficiency
1 trial -
GTX-104
Grace Therapeutics
Aneurysmal Subarachnoid Hemorrhage (aSAH)
1 trial -
Imiquimod 5% cream
Grace Therapeutics
Superficial Basal Cell Carcinoma
1 trial -
QVM149
Grace Therapeutics
Asthma
1 trial -
CaPre (TM)
Grace Therapeutics
Hypertriglyceridemia
1 trial -
Clonidine
Grace Therapeutics
Pregnancy Related
1 trial -
Eat Well Live Well Nutrition Program
Grace Therapeutics
Diabetes or Diabetes Prevention
1 trial -
Ketamine
Grace Therapeutics
Obstetric Pain
1 trial -
Lipid Lowering Medication
Grace Therapeutics
Hypertriglyceridemia
1 trial -
GTX-101
Grace Therapeutics
Postherpetic Neuralgia
1 trial -
GTX-102 medium dose fast Period 1 and Period 2
Grace Therapeutics
Ataxia Telangiectasia
1 trial -
GTX-104
Grace Therapeutics
Aneurysmal Subarachnoid Hemorrhage
1 trial -
Hydromorphone
Grace Therapeutics
Pain
1 trial -
Ketamine (Ketalar)
Grace Therapeutics
Pain
1 trial -
Ketamine (Ketalar) Dose Level 1
Grace Therapeutics
Pain, Postoperative
1 trial -
Desvenlafaxine Succinate
Grace Therapeutics
Vascular Depression
1 trial -
Tirzepatide
Grace Therapeutics
Prader-Willi Syndrome
1 trial -
Apolipoprotein (ApoE) detection
Grace Therapeutics
Senile Plaques
1 trial -
Benralizumab
Grace Therapeutics
Asthma; Eosinophilic
1 trial -
Bupivacaine / fentaNYL
Grace Therapeutics
Depression, Postpartum
1 trial -
ClearSight HPI Monitoring system
Grace Therapeutics
Anesthesia, Epidural
1 trial -
Control (Standard treatment)
Grace Therapeutics
Moisture Associated Skin Damage
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources